Slingshot members are tracking this event:
Portola (PTLA) FDA Advisory Committee Meeting in Q2 2017 for Betrixaban in the Prevention of VTE in Acute Medically Ill Patients
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Feb 08, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Fda, Advisory Committee Meeting, Betrixaban, Vte, Acute Medically Ill Patients